SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-21-291044
Filing Date
2021-10-04
Accepted
2021-10-04 16:58:44
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-3 d236019ds3.htm S-3 421300
2 EX-1.2 d236019dex12.htm EX-1.2 225652
3 EX-4.6 d236019dex46.htm EX-4.6 281660
4 EX-4.9 d236019dex49.htm EX-4.9 94413
5 EX-4.10 d236019dex410.htm EX-4.10 98875
6 EX-4.11 d236019dex411.htm EX-4.11 87526
7 EX-5.1 d236019dex51.htm EX-5.1 28721
8 EX-23.1 d236019dex231.htm EX-23.1 1679
9 GRAPHIC g236019dsp13.jpg GRAPHIC 3924
10 GRAPHIC g236019g35s74.jpg GRAPHIC 33656
  Complete submission text file 0001193125-21-291044.txt   1292847
Mailing Address 3985 SORRENTO VALLEY BLVD., SUITE C SAN DIEGO CA 92121
Business Address 3985 SORRENTO VALLEY BLVD., SUITE C SAN DIEGO CA 92121 858-369-7800
Metacrine, Inc. (Filer) CIK: 0001634379 (see all company filings)

IRS No.: 472297384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-260023 | Film No.: 211303662
SIC: 2834 Pharmaceutical Preparations